Junaid Mian, RPh’s Post

📢Robots and AI Revolutionize Cell and Gene Therapy Manufacturing 🤖 Researchers suggest that robots and artificial intelligence can address manufacturing challenges in cell and gene therapy. 🔬 The European Committee of ISCT and EBMT highlights the bottlenecks in manufacturing. ⬆️ The rapid growth of the sector necessitates skilled personnel and increased production demand. 🌍 Currently, there are only a few approved therapies, but the market is expected to expand. 🤖 Automation and robotization, combined with AI, can improve production efficiency and reduce costs and variability. #BioprocessUpdates #robots #artificialintelligence #celltherapy #genetherapy #manufacturing #research #bottlenecks #growth #skilledpersonnel #productiondemand #approvedtherapies #marketexpansion #automation #robotization #productionefficiency ▷ Read the full article here: 📎 https://lnkd.in/d_MpVg2x

The human genome, our biological blueprint, is a treasure trove of information waiting to be explored. As we delve deeper into its complexities, we're unlocking unprecedented opportunities to revolutionize healthcare. From personalized medicine to gene therapy, the potential applications are boundless. By harnessing the power of genomics and omics, we can advance the diagnosis, treatment, and prevention of diseases, ultimately improving the quality of life for countless individuals. The future of healthcare is genomic, and the possibilities are exciting. #molecularmedicine #multiomics #omics #precisionmedicine #translationalmedicine #translationalresearch

On equity, translation and the valley of death in biomedical innovation: " Recent transformative advances in health and medicine have successfully traversed the valley of death, including progress in genomics, precision medicine, innovative medicines and vaccines, gene therapy, and artificial intelligence. However, it is critical to call attention to a second, important valley of death: the failure to deliver scientific advances to populations most in need. The second valley of death is fueled by socioeconomic, environmental, political, and systemic factors." Dzau et al al write in JAMA. https://lnkd.in/e6Y-vJb2

Gene therapy developers often rely on empirical methods to generate vector library designs, limiting their libraries to just 10s of candidates for in vitro screening. This reduces the likelihood of finding the best lead candidate for clinical advancement. By using our in silico tools, we can create a comprehensive library of 1000s of designs, narrowing it down to the most promising candidates using AI/ML technology. Discover how we're accelerating the vector design process and increasing the probability of success. Download the Solutions Brief: https://hubs.li/Q02JCswm0 #GeneTherapy #AIML #InSilico #AI #VectorDesign

AI in Precision Medicine and Gene Editing: Transforming Healthcare #PrecisionMedicine #GeneEditing #AIHealthcare Experience the future of healthcare transformation with AI at the helm of precision medicine and gene editing—companies like Profluent and Caribou Biosciences harness artificial intelligence's power to revolutionize therapeutic development. From achieving unprecedented precision in genetic edits to predicting treatment outcomes with accuracy, AI is driving groundbreaking innovations that promise to enhance patient care and outcomes. Don't miss out on this exciting journey toward personalized medicine and the potential for transformative breakthroughs in healthcare. Let's dive into the basics of how it is done. Join the conversation now! #HealthTech #Innovation #AIAdvancements #FutureOfMedicine

There are exciting breakthroughs happening in gene editing! Researchers at Arc Institute and The University of Tokyo unveiled a new technique using bridge RNA derived from bacterial "jumping genes." Unlike #CRISPR, this method allows for precise DNA edits without breaking both strands, potentially revolutionizing therapies like #genetherapy and #celltherapy. This innovation promises to tackle genetic abnormalities with unprecedented accuracy and safety, paving the way for advanced biomedical applications. Click here to learn how Orchestra can help you unlock the power of RNA therapies: info@orchestralifesciences.com #biotech #facilitiesdesign #mRNA #cellandgenetherapy #engineering

At Ori Biotech we're passionate about improving patient access to life-saving cell and gene therapies. Reducing the cost, increasing the scale and enhancing the quality of the manufacturing process is how we're going to make a difference for patients. Digital transformation and automation of existing paper based records for manufacturing batch runs is enabling the realisation these benefits. Check out this The Medicine Maker article to learn more about how!

📄 Paper is holding back advanced therapy development. Matt Todd, our Director of Digital Solutions, shared his thoughts with The Medicine Maker about how paper-based processes are slowing progress in cell and gene therapy (CGT) manufacturing. Paper records can introduce significant inefficiencies and risks, from transcription errors to data retrieval delays. These slow down the manufacturing and development of these life-saving treatments and add unnecessary costs. To help enable widespread access to CGTs, we need to transition to automated, digitized solutions to automate better biology and accelerate product development. This is why we've developed IRO®, to support the move beyond paper and scale the impact of advanced therapies. Read more: https://lnkd.in/ewN-CaRD Learn more about IRO® and how it can help you scale your impact: https://oribiotech.com/iro #ManufacturingBrighterFutures #CellTherapy #GeneTherapy #PatientAccess #Biotechnology #ScaleYourImpact

🧬 AI designs synthetic DNA switches for precise gene control! Scientists at Yale, MIT, and Harvard have created thousands of novel DNA elements using AI, allowing for gene expression to be precisely controlled in specific cell types like blood, liver, or brain. This breakthrough could revolutionize gene therapy by enabling treatments targeted to one tissue without affecting the rest of the body. The platform, CODA (Computational Optimization of DNA Activity), uses deep learning to design entirely new CREs (cis-regulatory elements) with unprecedented specificity and effectiveness, paving the way for transformative applications in therapeutics and biomanufacturing. 💡 What’s your take? Could this AI-driven approach reshape the future of gene therapies and personalized medicine? #Biotech #ArtificialIntelligence #GeneTherapy #DNA #Innovation #MedicalResearch